Gene: DNM2
Official Full Name: dynamin 2provided by HGNC
Gene Summary: Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined. [provided by RefSeq, Jun 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00655 | DNM2 Knockout cell line(HEK293) | Human | DNM2 | 1:3~1:6 | Negative | Online Inquiry |
DNM2 Gene Knockout Cell Lines are finely engineered cellular models specifically designed to facilitate the study of the dynamin-2 (DNM2) protein functions. DNM2 is a key GTPase involved in clathrin-mediated endocytosis, membrane trafficking, and mitochondrial dynamics. By knocking out the DNM2 gene, these cell lines allow researchers to investigate the consequences of DNM2 deficiency, offering insight into various cellular processes and their implications for diseases, including neurodegenerative disorders, muscle atrophy, and cancer.
The knockout mechanism is typically achieved through advanced gene-editing technologies such as CRISPR-Cas9 or RNA interference, which effectively disrupt the targeted gene, enabling scientists to observe the resulting phenotypic and biochemical changes. Researchers utilizing these cell lines can conduct experiments that elucidate the role of DNM2 in vesicle formation, intracellular signaling, and cellular stress responses. This understanding is critical for uncovering pathogenic mechanisms and developing potential therapeutic strategies.
The scientific importance of DNM2 Gene Knockout Cell Lines extends into both basic and translational research, paving the way for breakthroughs in understanding how aberrant endosomal and mitochondrial dynamics contribute to various diseases. Compared to traditional cell lines that maintain the full functionality of DNM2, these knockout lines offer a unique opportunity to study cellular processes in a more controlled environment, eliminating confounding factors associated with gene expression variability.
Researchers and clinicians can benefit significantly from using DNM2 Gene Knockout Cell Lines, as these models provide robust platforms for drug screening, biomarker discovery, and investigating gene function in a relevant context. Their unique ability to mimic disease-related states allows for a deeper exploration into therapeutic targets, making them invaluable tools in the search for new treatments.
With extensive experience in molecular biology and cell line development, our company is dedicated to providing high-quality biological research tools that empower researchers to achieve impactful results. Our expertise ensures that each DNM2 Gene Knockout Cell Line is meticulously validated and consistent, supporting your research objectives with reliability and precision.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.